RLMD · ISSUER CIK 1553643
RELMADA THERAPEUTICS, INC.
Between Aug 1, 2026 and Oct 29, 2026, 2 RELMADA THERAPEUTICS, INC. insiders reported $1.7M of open-market purchases and $0.00 of sales on SEC Form 4. The largest buyer was Shenouda Maged (Chief Financial Officer), with $844K.
↗2 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$1.7MInsider buying
$0.00Insider selling
+$1.7MNet open-market
Sep 11, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 202607:30 | Sep 10, 2026from Sep 9, 2026 | RLMD | Chief Financial Officer | P · Buy | $4.22 | +200,000 | 1,000,000 | +25% | +$844K | -39.5% | -18.5% |
| Sep 11, 202607:30 | Sep 10, 2026from Sep 9, 2026 | RLMD | Chief Executive Officer, Director | P · Buy | $4.14 | +200,000 | 1,500,000 | +15% | +$828K | -40.7% | -16.9% |